An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology
- PMID: 29792263
- DOI: 10.1016/j.ygyno.2018.05.023
An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology
Erratum in
-
Corrigendum to "An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology" [Gynecol. Oncol. 150 (2018) 378-386].Gynecol Oncol. 2020 Jun;157(3):819. doi: 10.1016/j.ygyno.2020.03.014. Epub 2020 Apr 13. Gynecol Oncol. 2020. PMID: 32299629 No abstract available.
Abstract
Objective: One of the most common challenges in everyday clinical practice of gynecological oncology is to identify the type and the primary origin of a tumor. This is a crucial step in the management, treatment, prognosis, and survival of patients suffering from a gynecological malignancy. Immunohistochemistry has been widely adopted over the last three decades in pathology laboratories all over the world. Recent advances in our understanding of the differentiation of gynecological tumors based on immunohistochemical expression have resulted in use of immunohistochemistry as a major diagnostic tool in gynecology, for precise tumor classification. More recently, advances in molecular pathology, have taken this disease sub-classification further resulting in more effective personalised treatment regimens. The aim of this review is to provide clinicians with up to date information on the various immunohistochemical and molecular tests used in the diagnosis of gynecological malignancies of the female genital tract and an understanding of how to interpret them.
Methods: We performed a review of the current literature including review articles, original research articles, and guidelines on various immunohistochemical markers and molecular techniques which are used for the differential diagnosis of gynecologic malignancies.
Conclusions: Immunohistochemistry is useful as an objective means for improved diagnostic reproducibility, accuracy, and precise classification in cases where the diagnosis with histochemical stains is inconclusive, providing a more reliable estimate of clinical outcomes. The diagnosis, in some cases, can be further refined by the use of molecular techniques leading to personalised medical treatments.
Keywords: Immunohistochemical markers; Immunohistochemistry; Immunohistochemistry in gynecological oncology; Molecular markers; Molecular pathology in gynecological oncology; Review of immunohistochemistry in gynecological oncology.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Immunohistochemistry in gynecological pathology.Int J Gynecol Cancer. 2003 Sep-Oct;13(5):567-79. doi: 10.1046/j.1525-1438.2003.13387.x. Int J Gynecol Cancer. 2003. PMID: 14675338 Review.
-
The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders.Arch Pathol Lab Med. 2015 Jan;139(1):39-54. doi: 10.5858/arpa.2014-0057-RA. Arch Pathol Lab Med. 2015. PMID: 25549143 Review.
-
Clinical applications of immunohistochemistry in gynecological malignancies.Int J Gynecol Cancer. 2007 Mar-Apr;17(2):311-5. doi: 10.1111/j.1525-1438.2006.00759.x. Int J Gynecol Cancer. 2007. PMID: 17362308 Review.
-
Immunohistochemistry in Gynecologic Pathology: An Example-Based Practical Update.Arch Pathol Lab Med. 2017 Aug;141(8):1052-1071. doi: 10.5858/arpa.2016-0541-RA. Arch Pathol Lab Med. 2017. PMID: 28745567 Review.
-
Diagnostic immunohistochemistry in gynaecological neoplasia: a brief survey of the most common scenarios.J Clin Pathol. 2018 Feb;71(2):98-109. doi: 10.1136/jclinpath-2017-204787. Epub 2017 Nov 28. J Clin Pathol. 2018. PMID: 29183921 Review.
Cited by
-
Studies on healthy and neoplastic tissues using positron annihilation lifetime spectroscopy and focused histopathological imaging.Sci Rep. 2020 Jul 17;10(1):11890. doi: 10.1038/s41598-020-68727-3. Sci Rep. 2020. PMID: 32681103 Free PMC article.
-
Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway.Cancer Lett. 2019 Aug 28;458:92-101. doi: 10.1016/j.canlet.2019.05.029. Epub 2019 May 24. Cancer Lett. 2019. PMID: 31129149 Free PMC article.
-
Direct Cell⁻Cell Interactions in the Endometrium and in Endometrial Pathophysiology.Int J Mol Sci. 2018 Jul 30;19(8):2227. doi: 10.3390/ijms19082227. Int J Mol Sci. 2018. PMID: 30061539 Free PMC article. Review.
-
Utilization of immunohistochemistry in gynecologic tumors: An expert review.Gynecol Oncol Rep. 2024 Nov 29;56:101550. doi: 10.1016/j.gore.2024.101550. eCollection 2024 Dec. Gynecol Oncol Rep. 2024. PMID: 39717157 Free PMC article. Review.
-
Changes in the expression of Notch and Wnt signalling molecules in human endometrial cancer.Acta Med Litu. 2019;26(3):181-190. doi: 10.6001/actamedica.v26i3.4148. Acta Med Litu. 2019. PMID: 32015673 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources